Literature DB >> 21181166

Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts.

Hiroyuki Eda1, Hideaki Shimada, David R Beidler, Joseph B Monahan.   

Abstract

The aim of this study is to investigate the induction of interleukin-34 (IL-34) and macrophage colony-stimulating factor (M-CSF) mRNA by inflammatory cytokines and the involvement of mitogen-activated protein kinases (MAPKs) in this signaling pathway in human osteoblasts as both IL-34 and M-CSF bind to the same receptor c-FMS. Among four inflammatory cytokines [(IL-1β, IL-6, IL-17, and tumor necrosis factor-α (TNF-α)], IL-34 mRNA expression level was dramatically induced by IL-1β (17-fold) and TNF-α (74-fold). IL-1β and TNF-α activated the intracellular mitogen-activated protein kinases (MAPKs): p44/42 MAPK, p38, and c-Jun N-terminal kinase (JNK) as well as nuclear factor-κB (NF-κB) in osteoblasts. IL-1β- and TNF-α-mediated induction of IL-34 mRNA expression was decreased by JNK inhibitor. Interestingly, although treatment of MEK-1/2 inhibitor showed no reduction in the increase of IL-34 mRNA expression by cytokines, combination of MEK-1/2 inhibitor and JNK inhibitor significantly inhibited IL-1β- and TNF-α-mediated IL-34 mRNA expression level compared to those by each inhibitor alone. On the other hand, M-CSF mRNA expression level was significantly induced by both IL-1β and TNF-α by up to 7- and 11-fold, respectively. IL-1β- and TNF-α-mediated induction of M-CSF mRNA was not affected by p38, JNK, and MEK-1/2 inhibitors. However, NF-κB inhibitor completely inhibited the elevation of M-CSF mRNA expression by these cytokines. These results showed that proinflammatory cytokines, IL-1β and TNF-α, induced the expression of IL-34 mRNA via JNK and p44/42 MAPK but not p38 in human osteoblasts while p38, JNK, and p44/42 MAPK were not involved in the induction of M-CSF mRNA expression by these cytokines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181166     DOI: 10.1007/s00296-010-1688-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.

Authors:  S Kotake; N Udagawa; N Takahashi; K Matsuzaki; K Itoh; S Ishiyama; S Saito; K Inoue; N Kamatani; M T Gillespie; T J Martin; T Suda
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Human periodontal ligament cells secrete macrophage colony-stimulating factor in response to tumor necrosis factor-alpha in vitro.

Authors:  Tussanee Yongchaitrakul; Kanokporn Lertsirirangson; Prasit Pavasant
Journal:  J Periodontol       Date:  2006-06       Impact factor: 6.993

Review 3.  Colony-stimulating factor-1 in immunity and inflammation.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Opin Immunol       Date:  2005-12-06       Impact factor: 7.486

4.  Inhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression.

Authors:  P J Kamthong; M Wu
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

Review 5.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

6.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene.

Authors:  H Yoshida; S Hayashi; T Kunisada; M Ogawa; S Nishikawa; H Okamura; T Sudo; L D Shultz; S Nishikawa
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

7.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

8.  c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.

Authors:  M Repici; L Mare; A Colombo; C Ploia; A Sclip; C Bonny; P Nicod; M Salmona; T Borsello
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

9.  Discovery of a cytokine and its receptor by functional screening of the extracellular proteome.

Authors:  Haishan Lin; Ernestine Lee; Kevin Hestir; Cindy Leo; Minmei Huang; Elizabeth Bosch; Robert Halenbeck; Ge Wu; Aileen Zhou; Dirk Behrens; Diane Hollenbaugh; Thomas Linnemann; Minmin Qin; Justin Wong; Keting Chu; Stephen K Doberstein; Lewis T Williams
Journal:  Science       Date:  2008-05-09       Impact factor: 47.728

10.  Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters.

Authors:  N Kutukculer; S Caglayan; F Aydogdu
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

View more
  27 in total

1.  Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells.

Authors:  H Huang; N Zhao; X Xu; Y Xu; S Li; J Zhang; P Yang
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

2.  Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis.

Authors:  Sung Hae Chang; Byoong Yong Choi; Jungbum Choi; Jong Jin Yoo; You-Jung Ha; Hyon Joung Cho; Eun Ha Kang; Yeong Wook Song; Yun Jong Lee
Journal:  Rheumatol Int       Date:  2014-06-11       Impact factor: 2.631

3.  The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson's Disease in Rats.

Authors:  Zhijuan Mao; Chanchan Liu; Suqiong Ji; Qingmei Yang; Hongxiang Ye; Haiyan Han; Zheng Xue
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

Review 4.  Functions of interleukin-34 and its emerging association with rheumatoid arthritis.

Authors:  Ren-Peng Zhou; Xiao-Shan Wu; Ya-Ya Xie; Bei-Bei Dai; Wei Hu; Jin-Fang Ge; Fei-Hu Chen
Journal:  Immunology       Date:  2016-09-23       Impact factor: 7.397

Review 5.  Cancer-induced oxidative stress and pain.

Authors:  Mina G Nashed; Matthew D Balenko; Gurmit Singh
Journal:  Curr Pain Headache Rep       Date:  2014-01

Review 6.  Amphibian macrophage development and antiviral defenses.

Authors:  Leon Grayfer; Jacques Robert
Journal:  Dev Comp Immunol       Date:  2015-12-15       Impact factor: 3.636

7.  Divergent antiviral roles of amphibian (Xenopus laevis) macrophages elicited by colony-stimulating factor-1 and interleukin-34.

Authors:  Leon Grayfer; Jacques Robert
Journal:  J Leukoc Biol       Date:  2014-09-04       Impact factor: 4.962

8.  Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis.

Authors:  Seung-Jun Hwang; Bongkun Choi; Soon-Suk Kang; Jae-Ho Chang; Yong-Gil Kim; Yeon-Ho Chung; Dong Hyun Sohn; Min Wook So; Chang-Keun Lee; William H Robinson; Eun-Ju Chang
Journal:  Arthritis Res Ther       Date:  2012-01-20       Impact factor: 5.156

9.  Diagnostic Value of Interleukin-34 as a Novel Biomarker for Severity of Knee Osteoarthritis.

Authors:  Wanvisa Udomsinprasert; Kittaporn Panon; Siraphop Preechanukul; Jiraphun Jittikoon; Artit Jinawath; Sittisak Honsawek
Journal:  Cartilage       Date:  2021-02-08       Impact factor: 3.117

10.  The newly discovered cytokine IL-34 is expressed in gingival fibroblasts, shows enhanced expression by pro-inflammatory cytokines, and stimulates osteoclast differentiation.

Authors:  Elisabeth A Boström; Pernilla Lundberg
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.